The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma

Background: Renal cell carcinoma (RCC) is the most common malignancy in the urinary system. Despite substantial improvements in available treatment options, the survival outcome of advanced RCC is unsatisfactory. Identifying novel biomarkers to assist in early diagnosis and to screen patients who ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Keying, Xu, Chao, Liu, Shaojie, Jiang, Yao, Zhao, Xiaolong, Ma, Shanjin, Li, Yu, Yang, Fa, Wang, Yan, Meng, Ping, Shi, Changhong, Han, Donghui, Wen, Weihong, Qin, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006336/
https://www.ncbi.nlm.nih.gov/pubmed/33791227
http://dx.doi.org/10.3389/fonc.2021.644612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006336/
https://www.ncbi.nlm.nih.gov/pubmed/33791227
http://dx.doi.org/10.3389/fonc.2021.644612

Ejemplares similares